Clinical Trials List
2023-11-01 - 2035-12-31
Phase III
Recruiting7
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- YEN-TING LIN Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- 黃得瑞 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- 林宗哲 Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 徐偉勛 Division of Hematology & Oncology
- 吳尚俊 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 黃得瑞 Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- YEN-TING LIN Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shih-Hsin Hsiao Division of Thoracic Medicine
- Shang-Fu Hsu Division of Thoracic Medicine
- Pai-Chien Chou Division of Thoracic Medicine
- Chun-Liang Chou Division of Thoracic Medicine
- Chi-Li Chung Division of Thoracic Medicine
- Mei-Chuan Chen Division of Thoracic Medicine
- Kai-Ling Lee Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- 林志鴻 Division of Thoracic Surgery
- JENG-SEN TSENG Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
- 莊政諺 Division of Thoracic Surgery
- 李柏昕 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 葉金水 Division of Thoracic Medicine
- 黃國揚 Division of Thoracic Medicine
- 張竣期 Division of Thoracic Medicine
- 施穎銘 Division of Thoracic Medicine
- 詹博強 Division of Thoracic Medicine
- 陳正雄 Division of Thoracic Medicine
- 林俊維 Division of Thoracic Medicine
- 蔡偉宏 Division of Thoracic Medicine
- 林慶雄 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
- 林明泰 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Hui Lee 無
- Chin-Wei Kuo 無
- Seu-Chun Yang 無
- Yau-Lin Tseng 無
- 陳盈元 Division of General Surgery
- Shang-Yin Wu 無
- Chian-Wei Chen 無
- Wu-Chou Su 無
- 蔡政軒 無
- Yi-Ting Yen 無
- 黃維立 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
36 participants
-
Global
868 participants
